Febuxostat-d7 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Febuxostat-d7, is the labeled analogue of Febuxostat-d7 (F229000), a Xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout.

Febuxostat-d7 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Febuxostat-d7 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Dideu Industries Group Limited	+86-29-89586680 +86-15129568250	1059@dideu.com	China	29119	58
BOC Sciences	16314854226; +8616314854226	inquiry@bocsci.com	United States	19853	58
TargetMol Chemicals Inc.	13564774135	marketing@targetmol.com	United States	19956	58
Cato Research Chemicals Inc.	020-81960175	min.he@cato-chem.com	China	1955	55
Quality Control Solutions Ltd.	0755-66853366 13670046396	orders@qcsrm.com	China	18190	56
Shanghai Champ Biopharmaceuticals Co., Ltd.	021-61537865 13585780846	sales@champchem.com	China	445	58
Lynnchem	86-(0)29-85992781 17792393971	info@lynnchem.com	China	4587	58
Novachemistry	44-20819178-90 02081917890	info@novachemistry.com	United Kingdom	4381	58
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226	sales@rrkchem.com	China	57422	58
Hefei Molake Biotechnology Co., Ltd.	0551-66336380 18956014586	983438788@qq.com	China	2419	58

1285539-74-3()Verwandte Suche:

---

• Febuxostat-d7
• BQSJTQLCZDPROO-SCENNGIESA-N
• 2-[3-Cyano-4-(2-methylpropoxyphenyl]-4-methyl-5-thiazolecarboxylic Acid-d7
• [2H7]-Febuxostat
• Dapagliflozin Impurity 139
• 1285539-74-3
• 85539-74-3